Evidence map›Paper›PMID 24474306›Full record

ArticleJAMA internal medicine2014

Antibiotic judo: working gently with prescriber psychology to overcome inappropriate use.

Brad Spellberg

Abstract readComment
In one paragraph

Article in JAMA internal medicine, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Trial
  2. Article
  3. Antimicrobial ethicists: Making ethics explicit in antimicrobial stewardship.Antimicrobial stewardship & healthcare epidemiology : ASHE · 2021
    Article
  4. Article
  5. Short-course Antibiotic Therapy-Replacing Constantine Units With "Shorter Is Better".Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2019
    Article
  6. Antimicrobial Stewardship in the Emergency Department.Emergency medicine clinics of North America · 2018
    Review
  7. Article
  8. Article
  9. Article
  10. Novel approaches are needed to develop tomorrow's antibacterial therapies.American journal of respiratory and critical care medicine · 2015
    Review
  11. Article
  12. The future of antibiotics and resistance: a tribute to a career of leadership by John Bartlett.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2014
    Article
  13. Article
  14. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

1 author.

Brad SpellbergDivision of General Internal Medicine, Harbor-UCLA Medical Center, Los Angeles, California2Los Angeles Biomedical Research Institute, Torrance, California3David Geffen School of Medicine at UCLA, Los Angeles, California.

Funding

Antibacterial Resistance Leadership Group (ARLG)UM1AI104681 · NIAID · DUKE UNIVERSITY · PI Vance G. Fowler, Henry F HENRY CHAMBERS · 2013 to 2026
$180.8M
A New Approach to Staphylococcus aureus Vaccine Development - Resubmission 01R01AI103342 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI DAUM, ROBERT S., LEE, JEAN CLAIRE · 2013 to 2016
$2.1M
Activated Targeted Killer (ATAK) Cells for Invasive Fungal InfectionsR01AI081719 · NIAID · LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER · PI SPELLBERG, BRAD J · 2009 to 2013
$1.7M
Acinetobacter virulence and host innunopathogenesisR21AI101750 · NIAID · UNIVERSITY OF SOUTHERN CALIFORNIA · PI SPELLBERG, BRAD J · 2013 to 2014
$434k
Antibody Targeting of KPC and NDM1R21AI101492 · NIAID · UNIVERSITY OF SOUTHERN CALIFORNIA · PI SPELLBERG, BRAD J · 2013 to 2014
$417k
NIAID NIH HHS AI101750NIAID NIH HHS AI103342NIAID NIH HHS R01 AI081719NIAID NIH HHS R01 AI103342NIAID NIH HHS R01S AI081719NIAID NIH HHS R21 AI101492NIAID NIH HHS R21 AI101750NIAID NIH HHS R21S AI101492NIAID NIH HHS UM1 AI104681NIAID NIH HHS UM1AI104681
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Drug PrescriptionsGuideline AdherencePractice Guidelines as TopicPractice Patterns, Physicians'Anti-Bacterial AgentsHumansInappropriate PrescribingInfectionsMaleAnti-Bacterial Agents

Identifiers

PMID24474306
PMCPMC4064591

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.